Discover: Beyond Legal – Navigating the pre-IPO to Public Company Transition

Time: 3:20 pm
day: Conference Day One


• Life science companies are unique – many life science companies that prepare for an IPO are leanly-staffed, pre-commercial stage and/or managed by an executive team that is not experienced with the IPO process or being a public company
• Pre-IPO and newly-public life science companies can be better prepared to handle the major shift in focus, operations and processes that follows an IPO
• Beyond the legal aspects of an IPO and complying with legal requirements post-IPO, in-house counsel can be key business partners in the transition phase by identifying and helping to mitigate (typically non-legal) pain points earlier in the process